‘In the field of drug development we have something very special in the Northern Netherlands,’ said Deputy Patrick Brouns at the launch of the “Pharma Portal” and the fund “Pharma Connect Capital” on October 12th. By combining regional strong expertise in the Pharma Portal and risk capital in Pharma Connect Capital, Groningen’s strength in developing new drugs is accelerated, which will boost the improvement of healthcare globally.
The combination of the Pharma Portal and Pharma Connect Capital, in which investors, academic organizations and companies work closely together is unique in the Netherlands. Within the Portal and the fund knowledge and risk investments are connected seamlessly.
Pharma Portal; Promising initiatives
In order to let the number of high-quality initiatives grow, a strong link has been established with the new Pharma Portal. Within the portal, young pharmaceutical initiatives are accompanied and accelerated. The portal serves as a quality system and quality mark. The Pharma Portal adds expertise based on long-term experience in the international pharma industry. The concepts are independently assessed on content and commercial potential. This is the first cornerstone of an ecosystem with promising initiatives. Ready to be invested in.
The aim of the Pharma Portal is to:
1. To contribute to the development of new medicines in order to increase the chance of (commercial) success;
2. Obtain 2 to 5 early phase propositions in the clinic within 5 years and / or license / sell to the pharmaceutical industry;
3. To promote and develop cooperation between knowledge institutions and SMEs and to promote SME cooperation at a higher level;
4. Strengthen the competitive position of the Northern Netherlands with new propositions within the Life Sciences.
This project is made possible by: